agilon health, inc. (NYSE:AGL) Receives $3.95 Average Price Target from Brokerages

agilon health, inc. (NYSE:AGL) has received a consensus rating of “Hold” from the seventeen brokerages that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $4.37.

A number of equities analysts have weighed in on the stock. Sanford C. Bernstein raised shares of agilon health from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $3.30 to $8.50 in a research note on Tuesday. Macquarie began coverage on agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price on the stock. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and boosted their price target for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Stifel Nicolaus upped their price target on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Friday, March 21st.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in agilon health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock worth $59,114,000 after buying an additional 272,787 shares during the period. Capital International Investors increased its stake in shares of agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after buying an additional 9,346,295 shares during the last quarter. State Street Corp increased its position in shares of agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Millennium Management LLC raised its stake in agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after buying an additional 4,706,357 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after acquiring an additional 35,207 shares in the last quarter.

agilon health Trading Up 6.5 %

NYSE AGL opened at $5.52 on Friday. The company has a market cap of $2.27 billion, a P/E ratio of -5.87 and a beta of 0.38. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a 50-day moving average of $3.94 and a 200-day moving average of $3.06.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.